PRODUCT DESCRIPTION:

Oxytocin Injection is a synthetic form of the naturally occurring hormone used widely in obstetrics to stimulate uterine contractions. It plays a pivotal role in the induction and augmentation of labor, management of third-stage labor, and prevention or treatment of postpartum hemorrhage (PPH) a leading cause of maternal mortality.

Our Oxytocin Injection is manufactured under WHO-GMP compliant facilities, ensuring stringent quality, potency, and cold-chain stability. Offered in both 5 IU/mL and 10 IU/mL concentrations, the product meets the varying clinical needs of labor management protocols across healthcare settings.

This essential medicine is recommended by WHO and prominently featured in maternal health kits by UN agencies, NGOs, and public health procurement bodies.

Formulation & Presentation:

• Dosage Form: Sterile Injectable
• Presentation: Clear Sterile Solution in Clear/Amber Glass Vial/ Ampoule (customizable as per market demand)
• Available Strengths:
  • 5 IU/ mL
  • 10 IU/ mL
• Route of Administration: For Intramuscular (IM) or Intravenous (IV) slow infusion (with dilution, under medical supervision) after appropriate reconstitution or as per clinical indication and severity. Reconstituted as per protocol for injection in country of use. To be administered under strict supervision of a qualified doctor or as per physician’s discretion or decision only.

Therapeutic Indications:

• Induction and augmentation of labor
• Management of postpartum hemorrhage (PPH)
• Uterine atony following delivery
• Facilitation of uterine involution post-abortion or delivery

Side Effects:

• COMMON:
  • Nausea or vomiting
  • Abdominal cramping
  • Headache
  • Flushing
• SERIOUS (RARE):
  • Uterine hyperstimulation or rupture
  • Hypotension or hypertension
  • Water intoxication (due to antidiuretic effect)
  • Cardiac arrhythmias
  • Anaphylactic reactions
• PRECAUTIONS:
  • Use with caution in multiparous women and those with previous uterine surgery
  • Continuous fetal monitoring is recommended during administration
  • Avoid rapid IV bolus administration
  • Caution in patients with cardiovascular disease, renal impairment, or preeclampsia
  • Contraindicated in obstructed labor or fetal distress when delivery is not imminent